CBD Shifted Immune Responses in Blood Cells from Psoriasis Patients
In lab experiments with blood cells from psoriasis patients, CBD shifted immune responses from inflammatory Th1 toward anti-inflammatory Th2, boosted natural killer cell activity, and blocked inflammatory immune cell migration.
Quick Facts
What This Study Found
CBD shifted immune responses from Th1 to Th2, boosted NK cell cytotoxic activity, blocked monocyte migration in response to inflammatory stimuli, prevented full dendritic cell maturation, and promoted M2 (anti-inflammatory) macrophage polarization in PBMCs from psoriasis patients.
Key Numbers
CBD effects tested on: Th1/Th2 balance, NK cell cytotoxicity, monocyte migration, dendritic cell maturation, M2 macrophage polarization; all in psoriasis patient PBMCs
How They Did This
In vitro immune functional experiments testing CBD effects on various immune cell types (T cells, NK cells, monocytes, dendritic cells, macrophages) isolated from peripheral blood of individuals with psoriasis vulgaris.
Why This Research Matters
Psoriasis is driven by overactive immune responses in the skin. These results suggest CBD could address multiple immune pathways simultaneously, which is unusual for a single compound and could make it a versatile anti-inflammatory agent.
The Bigger Picture
Current psoriasis treatments often target single immune pathways. CBD's ability to modulate multiple immune cell types simultaneously could represent a new therapeutic approach, though these are lab findings that need clinical validation.
What This Study Doesn't Tell Us
In vitro study only. Immune cell behavior in a dish may not reflect what happens in living skin tissue. No clinical outcomes measured. The doses used may not be achievable in human skin.
Questions This Raises
- ?Would topical CBD application produce similar immune-modulating effects in psoriatic skin lesions?
- ?Could CBD complement existing biologic therapies for psoriasis?
Trust & Context
- Key Stat:
- CBD modulated 5 different immune cell types simultaneously in psoriasis patient blood cells
- Evidence Grade:
- In vitro study with no clinical component. Demonstrates biological plausibility but far from clinical evidence.
- Study Age:
- Published in 2024.
- Original Title:
- Cannabidiol exerts multitarget immunomodulatory effects on PBMCs from individuals with psoriasis vulgaris.
- Published In:
- Frontiers in immunology, 15, 1373435 (2024)
- Authors:
- Pagano, Cristina, Ciaglia, Elena, Coppola, Laura, Lopardo, Valentina, Raimondo, Annunziata, Giuseppe, Monfrecola, Lembo, Serena, Laezza, Chiara, Bifulco, Maurizio
- Database ID:
- RTHC-05603
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Could CBD treat psoriasis?
These lab results are promising but preliminary. CBD affected multiple immune pathways relevant to psoriasis, but clinical trials are needed to see if this translates to actual skin improvement.
How did CBD affect immune cells?
It shifted the immune balance from inflammatory (Th1) to anti-inflammatory (Th2), boosted natural killer cells, and prevented inflammatory immune cell migration and maturation.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-05603APA
Pagano, Cristina; Ciaglia, Elena; Coppola, Laura; Lopardo, Valentina; Raimondo, Annunziata; Giuseppe, Monfrecola; Lembo, Serena; Laezza, Chiara; Bifulco, Maurizio. (2024). Cannabidiol exerts multitarget immunomodulatory effects on PBMCs from individuals with psoriasis vulgaris.. Frontiers in immunology, 15, 1373435. https://doi.org/10.3389/fimmu.2024.1373435
MLA
Pagano, Cristina, et al. "Cannabidiol exerts multitarget immunomodulatory effects on PBMCs from individuals with psoriasis vulgaris.." Frontiers in immunology, 2024. https://doi.org/10.3389/fimmu.2024.1373435
RethinkTHC
RethinkTHC Research Database. "Cannabidiol exerts multitarget immunomodulatory effects on P..." RTHC-05603. Retrieved from https://rethinkthc.com/research/pagano-2024-cannabidiol-exerts-multitarget-immunomodulatory
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.